Literature DB >> 11453092

Toxicological detection of pholcodine and its metabolites in urine and hair using radio immunoassay, fluorescence polarisation immunoassay, enzyme immunoassay, and gas chromatography-mass spectrometry.

H H Maurer1, C F Fritz.   

Abstract

Pholcodine (3-O-(2'-morpholinoethyl)-morphine) is used in many countries as an antitussive without analgesic or addictive properties. It is of forensic relevance that pholcodine interferes with opiate immunoassays. In this paper a gas chromatographic-mass spectrometric (GC-MS) procedure for the precise and sensitive detection of pholcodine and its metabolites in urine and hair, after acid hydrolysis, extraction and acetylation, is presented. Furthermore, detection of pholcodine using radio immunoassay (RIA), fluorescence polarisation immunoassay (FPIA) and enzyme immunoassay (EIA) for opiates is described. Using GC-MS, unmodified pholcodine could be detected in urine samples 4-7 weeks after ingestion of a single therapeutic dose of 50mg of pholcodine, the desmorpholinohydroxy metabolite for 1-2 weeks and the other metabolites (nor-, nordesmorpholinohydroxy-, hydroxy-, oxo- and noroxo-pholcodine) only during the first few hours. Morphine could also be detected in urine samples for the first few days. It was however mainly formed artificially during acid hydrolysis and only in trace amounts by metabolism. All the immunoassays tested gave positive results in urine samples during the first week taking the cut-off values recommended by the manufacturer into consideration. If values between the cut-off and the detection limit were taken into consideration, RIA and FPIA gave positive results for 2-4 weeks and EIA up to 2 weeks. Pholcodine could also be detected by RIA and GC-MS in samples of head hair clipped 10 weeks after ingestion of 50mg and in daily shaved samples of beard hair over a period of three weeks after ingestion of three doses of 60mg. It can be concluded that the widely used immunoassays for opiates show positive results in urine and hair samples for a long time after ingestion of the non-opioid pholcodine and that these results can be confirmed by the GC-MS procedure described in this paper.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 11453092     DOI: 10.1007/BF01816483

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  6 in total

1.  [Chemical, pharmacological and clinical study of a new sedative for cough: morpholylethylmorphine].

Authors:  P CHABRIER; R GIUDICELLI; J THUILLIER
Journal:  Ann Pharm Fr       Date:  1950-04

2.  [Forensic-toxicologic detection of pholcodine in urine and hair].

Authors:  H H Maurer; C F Fritz
Journal:  Beitr Gerichtl Med       Date:  1990

3.  Metabolism of pholcodine in man.

Authors:  H H Maurer; C F Fritz
Journal:  Arzneimittelforschung       Date:  1990-05

Review 4.  Pholcodine.

Authors:  J W Findlay
Journal:  J Clin Pharm Ther       Date:  1988-02       Impact factor: 2.512

5.  Pharmacokinetics and O-dealkylation of morphine-3-alkyl ethers in the rat. A radioimmunoassay study.

Authors:  R F Butz; E C Jones; R M Welch; J W Findlay
Journal:  Drug Metab Dispos       Date:  1983 Sep-Oct       Impact factor: 3.922

6.  Pholcodine interference in the immunoassay for opiates in urine.

Authors:  G Svenneby; E Wedege; R L Karlsen
Journal:  Forensic Sci Int       Date:  1983 May-Jun       Impact factor: 2.395

  6 in total
  4 in total

1.  Detection of drugs in human hair for clinical and forensic applications.

Authors:  P Kintz; A Tracqui; P Mangin
Journal:  Int J Legal Med       Date:  1992       Impact factor: 2.686

2.  Instantaneous rigor after fatal pholcodine intoxication.

Authors:  Pierre Esnault; Bertrand Prunet; Guillaume Lacroix; Erwan D'Aranda; Yvan Gaillard; Henry Boret
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

3.  Paper-based potentiometric sensing devices modified with chemically reduced graphene oxide (CRGO) for trace level determination of pholcodine (opiate derivative drug).

Authors:  Hisham S M Abd-Rabboh; Abd El-Galil E Amr; Elsayed A Elsayed; Ahmed Y A Sayed; Ayman H Kamel
Journal:  RSC Adv       Date:  2021-03-26       Impact factor: 4.036

4.  Pharmacological studies on meprobamate incorporation in human beard hair.

Authors:  P Kintz; A Tracqui; P Mangin
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.